HBI-002, Vehicle (placebo) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, a
Phase 2 · Parkinson Disease |
Hillhurst Biopharmaceuticals, Inc. | HBI-002, Vehicle (placebo) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|